Showing results (61-70 of 901) with videos related to
Sort By:
Pageof 91
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1993
Use of didanosine in zidovudine-intolerant patients infected with human immunodeficiency virusM R Nelson, G J Moyle, B G GazzardThe AIDS Reader|September 1, 2000
Switching from a PI-based to a PI-sparing regimen for management of metabolic or clinical fat redistributionG Moyle, C BaldwinHIV Medicine|April 28, 2007
Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trialsA Hill, G MoyleInternational Journal of STD & AIDS|July 1, 1993
Causes of weight loss in human immunodeficiency virus infectionC D Summerbell, J P Perrett, B G GazzardBritish Medical Journal|January 24, 1976
Why do people use paracetamol for suicide?B G Gazzard, M Davis, J Spooner, et al.The Journal of Infection|September 5, 2001
The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinicN J Ives, B G Gazzard, P J EasterbrookThe Journal of Infection|January 1, 1997
Central venous line infections in AIDSD A Moore, B G Gazzard, M R NelsonGut|February 1, 1974
A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosisB G Gazzard, R Clark, V Borirakchanyavat, et al.Genitourinary Medicine|April 1, 1990
Fixed drug eruption due to foscarnetG M Connolly, B G Gazzard, D A HawkinsAIDS (London, England)|November 1, 1996
The metabolic response to opportunistic infections in AIDSD R Sharpstone, H M Ross, B G GazzardPageof 91